The SP/NK-1R system mediates doxorubicin cardiotoxicity and chemoresistance; in fact, in tumor cells, aprepitant increases doxorubicin induced reduction of cell viability, ROS synthesis and cell death by apoptosis, whereas in normal cardiomyocytes, the same drug exerts opposite effects [108]. The gene discussed is TACR1; the disease is neoplasm.